Situation

$4B public medical device company. After two years of merger under performance, board of directors exited several senior executives including the CEO and COO simultaneously. The business required an immediate backstop to ensure operational stability and maintain the confidence of customers, investors and employees. The board also needed time to execute a formal search for qualified replacements.

Action

As interim President and COO, worked with the board and interim CEO to support the transition process including the replacement of the CFO and GC. Led the global business through the transition to a new CEO after 6 months.

Result

Delivered significant organizational changes during the transition period including consolidation of the global operating structure from 7 reporting units to 5 and the elimination of 2 executive layers. Re-energized a struggling integration effort from a large merger 2 years prior.